vs
EMPIRE PETROLEUM CORP（EP）与Immunovant, Inc.（IMVT）财务数据对比。点击上方公司名可切换其他公司
Immunovant, Inc.的季度营收约是EMPIRE PETROLEUM CORP的1.2倍（$8.4M vs $7.1M），EMPIRE PETROLEUM CORP净利率更高（-835.1% vs -899.0%，领先63.9%），Immunovant, Inc.同比增速更快（140.7% vs -30.0%）
伊拉克石油公司，前身为土耳其石油公司，是一家石油企业，1925年至1961年间几乎垄断了伊拉克境内所有石油勘探与开采业务，由当时全球多家顶尖石油企业共同持股，公司总部设立于英国伦敦。
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
EP vs IMVT — 直观对比
营收规模更大
IMVT
是对方的1.2倍
$7.1M
营收增速更快
IMVT
高出170.8%
-30.0%
净利率更高
EP
高出63.9%
-899.0%
损益表 — Q4 FY2025 vs Q4 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $7.1M | $8.4M |
| 净利润 | $-59.0M | $-75.3M |
| 毛利率 | — | — |
| 营业利润率 | -834.5% | -896.2% |
| 净利率 | -835.1% | -899.0% |
| 营收同比 | -30.0% | 140.7% |
| 净利润同比 | -1306.0% | -26.7% |
| 每股收益（稀释后） | $-1.74 | $-0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EPIMVT
| Q4 25 | $7.1M | — | ||
| Q3 25 | $9.4M | — | ||
| Q2 25 | $8.8M | — | ||
| Q1 25 | $9.0M | — | ||
| Q4 24 | $10.1M | — | ||
| Q3 24 | $11.4M | — | ||
| Q2 24 | $12.8M | — | ||
| Q1 24 | $9.4M | $8.4M |
净利润EPIMVT
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $-3.8M | — | ||
| Q2 25 | $-5.1M | — | ||
| Q1 25 | $-4.2M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-3.6M | — | ||
| Q2 24 | $-4.4M | — | ||
| Q1 24 | $-4.0M | $-75.3M |
营业利润率EPIMVT
| Q4 25 | -834.5% | — | ||
| Q3 25 | -37.8% | — | ||
| Q2 25 | -56.0% | — | ||
| Q1 25 | -43.9% | — | ||
| Q4 24 | -38.9% | — | ||
| Q3 24 | -30.0% | — | ||
| Q2 24 | -15.0% | — | ||
| Q1 24 | -46.8% | -896.2% |
净利率EPIMVT
| Q4 25 | -835.1% | — | ||
| Q3 25 | -40.9% | — | ||
| Q2 25 | -57.8% | — | ||
| Q1 25 | -46.9% | — | ||
| Q4 24 | -41.6% | — | ||
| Q3 24 | -32.0% | — | ||
| Q2 24 | -34.3% | — | ||
| Q1 24 | -42.3% | -899.0% |
每股收益（稀释后）EPIMVT
| Q4 25 | $-1.74 | — | ||
| Q3 25 | $-0.11 | — | ||
| Q2 25 | $-0.15 | — | ||
| Q1 25 | $-0.12 | — | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $-0.12 | — | ||
| Q2 24 | $-0.15 | — | ||
| Q1 24 | $-0.15 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2M | $635.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-4.6M | $617.8M |
| 总资产 | $65.9M | $666.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EPIMVT
| Q4 25 | $1.2M | — | ||
| Q3 25 | $4.6M | — | ||
| Q2 25 | $2.3M | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $2.3M | — | ||
| Q3 24 | $3.1M | — | ||
| Q2 24 | $9.3M | — | ||
| Q1 24 | $3.5M | $635.4M |
总债务EPIMVT
| Q4 25 | — | — | ||
| Q3 25 | $15.2M | — | ||
| Q2 25 | $14.6M | — | ||
| Q1 25 | $11.6M | — | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.5M | — |
股东权益EPIMVT
| Q4 25 | $-4.6M | — | ||
| Q3 25 | $53.7M | — | ||
| Q2 25 | $54.5M | — | ||
| Q1 25 | $59.1M | — | ||
| Q4 24 | $62.8M | — | ||
| Q3 24 | $56.5M | — | ||
| Q2 24 | $58.7M | — | ||
| Q1 24 | $31.7M | $617.8M |
总资产EPIMVT
| Q4 25 | $65.9M | — | ||
| Q3 25 | $123.0M | — | ||
| Q2 25 | $124.7M | — | ||
| Q1 25 | $123.7M | — | ||
| Q4 24 | $123.9M | — | ||
| Q3 24 | $121.2M | — | ||
| Q2 24 | $119.9M | — | ||
| Q1 24 | $100.1M | $666.4M |
负债/权益比EPIMVT
| Q4 25 | — | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.8M | $-59.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-59.8M |
| 自由现金流率自由现金流/营收 | — | -714.4% |
| 资本支出强度资本支出/营收 | — | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-214.6M |
8季度趋势，按日历期对齐
经营现金流EPIMVT
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $330.0K | — | ||
| Q2 25 | $-3.1M | — | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $-8.8M | — | ||
| Q3 24 | $12.8M | — | ||
| Q2 24 | $-1.8M | — | ||
| Q1 24 | $3.9M | $-59.7M |
自由现金流EPIMVT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-59.8M |
自由现金流率EPIMVT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -714.4% |
资本支出强度EPIMVT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
